Rifagut® 200 contains rifaximin 200 mg, a broad-spectrum antimicrobial agent that remains largely within the digestive tract, allowing targeted activity against susceptible intestinal bacteria while minimizing systemic absorption.

Rifaximin is widely used for the management of gastrointestinal conditions associated with bacterial overgrowth and intestinal dysbiosis. Its localized action in the gut makes it a commonly utilized option in treatment protocols involving altered intestinal microbiota and bacterial imbalance.

In integrative clinical practice, rifaximin may be considered by healthcare professionals as part of broader gastrointestinal and microbiome-support strategies when clinically appropriate.

Treatment decisions, dosage schedules, and duration of therapy should always be determined by a qualified healthcare professional.